XWRQJNKFZWFOAZ-JAQHITNDSA-N
C32H33F4N7O4 — CID 121455584
Data last refreshed: (MolForge compound catalog, from PubChem)
About XWRQJNKFZWFOAZ-JAQHITNDSA-N
XWRQJNKFZWFOAZ-JAQHITNDSA-N (PubChem CID 121455584) has the molecular formula C32H33F4N7O4 and a molecular weight of 655.65 g/mol. Its IUPAC name is 4-[(2R,5S)-2-[8-amino-1-[2-fluoro-4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-5-methylmorpholin-4-yl]-1-methylcyclohexane-1-carboxylic acid.
Molecular Properties
| Compound Name | XWRQJNKFZWFOAZ-JAQHITNDSA-N |
|---|---|
| PubChem CID | 121455584 |
| Molecular Formula | C32H33F4N7O4 |
| Molecular Weight | 655.65 g/mol |
| Exact Mass | 655.25 |
| IUPAC Name | 4-[(2R,5S)-2-[8-amino-1-[2-fluoro-4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-5-methylmorpholin-4-yl]-1-methylcyclohexane-1-carboxylic acid |
| SMILES | C[C@H]1CO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C1CCC(C)(C(=O)O)CC1 |
| InChI | InChI=1S/C32H33F4N7O4/c1-17-16-47-23(15-43(17)20-5-8-31(2,9-6-20)30(45)46)28-41-25(26-27(37)39-11-12-42(26)28)21-4-3-18(13-22(21)33)29(44)40-24-14-19(7-10-38-24)32(34,35)36/h3-4,7,10-14,17,20,23H,5-6,8-9,15-16H2,1-2H3,(H2,37,39)(H,45,46)(H,38,40,44)/t17-,20?,23+,31?/m0/s1 |
| InChIKey | XWRQJNKFZWFOAZ-UXJDWXCFSA-N |
| XLogP | 5.58 |
| TPSA | 147.97 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 655.65 |
| LogP ≤ 5 | 5.58 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121455584 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.